Spearhead Capital Advisors, LLC Care Dx, Inc. Transaction History

Spearhead Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$20.49 - $39.72 $152,691 - $295,993	-7,452 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$28.19 - $46.6 $53,983 - $89,239	1,915 Added 34.59%	7,452 $276,000
Q4 2021 Jan 25, 2022	BUY	$41.2 - $73.6 $3,790 - $6,771	92 Added 1.69%	5,537 $252,000
Q3 2021 Oct 27, 2021	SELL	$59.15 - $91.99 $650 - $1,011	-11 Reduced 0.2%	5,445 $345,000
Q2 2021 Aug 10, 2021	BUY	$63.02 - $95.11 $45,437 - $68,574	721 Added 15.23%	5,456 $499,000
Q1 2021 Apr 28, 2021	SELL	$57.62 - $95.6 $305,846 - $507,444	-5,308 Reduced 52.85%	4,735 $322,000
Q4 2020 Feb 02, 2021	BUY	$41.43 - $77.09 $4,764 - $8,865	115 Added 1.16%	10,043 $728,000
Q3 2020 Oct 16, 2020	BUY	$30.88 - $37.94 $16,582 - $20,373	537 Added 5.72%	9,928 $377,000
Q2 2020 Jul 16, 2020	BUY	$18.95 - $35.43 $177,959 - $332,723	9,391 New	9,391 $333,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.21B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.